News

'Understanding herb-drug interactions' - NCE 2014

Professor Andrew McLachlan*, from the University of Sydney, School of Pharmacy (Aged Care) will be conducting a presentation on 'Understanding herb-drug interactions' at this year's NCE '14 - National Convention & Exhibition 2014, 20-22 June 2014 in Sydney. 

With many patients taking complementary medicines together with their prescription medications, it is important for pharmacists to be aware of the potential safety concerns surrounding this common practice. This session will detail common herb-drug interactions and consider the mechanism of a number of interactions and the quality of evidence to inform the safe and appropriate use of herbal medicines.

After the session pharmacists will be able to;

•    Identify some common interactions with complementary medicines

•    Recognise some strategies to reduce the risk of interaction

For further information about the IMgateway interactions database, developed in partnership with the University of Sydney, School of Pharmacy please contact UnityHealth on 1300 864 894 or email info@imgateway.net.

___________________________________________________________________________________________

As an added BONUS, subscribe to IMgateway (via eMIMs, AIMA or IMgateway) before 20 August 2014 to automatically go into a draw to win a dining experience for two at Attica - Australasia’s number 1 restaurant - plus $300 for travel/accommodation expenses.  Please call 1300 864 894 or email info@imgateway.net for further details.

___________________________________________________________________________________________

*Professor Andrew McLachlan is a pharmacist, academic and researcher with experience in clinical and experimental pharmacology and research into the Quality Use of Medicines.  Andrew is Professor of Pharmacy (Aged Care) in the School of Pharmacy at the University of Sydney based at Concord Hospital and the Centre for Education and Research on Ageing (CERA) at Concord Hospital, Sydney. His main research interests centre on understanding the causes and consequences of variability in response to medicines and how this informs their quality use.